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Salmonella Blockley is rarely isolated in the
Western Hemisphere. According to Enter-net,
the international network for surveillance of
Salmonella and verocytotoxin-producing Escheri-
chia coli infections, S. Blockley represented 0.6% of
all Salmonella serotypes isolated in Europe during
the first quarter of 1998, a full 100-fold lower
than the dominant serotype, S. Enteritidis
(67.1%) (1). However, S. Blockley is among the
five most frequently isolated serotypes from both
avian and human sources in Japan (2,3),
Malaysia (4,5), and Thailand (6). A single
foodborne outbreak in the United States (7) and
sporadic human infections in Europe associated
with travel to the Far East (8), animal infection
(9) or carriage (10,11), and environmental
isolates have also been reported (12,13).
Regardless of the frequency of S. Blockley
isolation, its rates of resistance to antibiotics
have been high. Among Spanish salmonellae
isolated from natural water reservoirs,
S.  Blockley and S. Typhimurium had the highest
rates of multidrug resistance (12). Comparing
1980-1989 with 1990-1994, researchers from
Tokyo noted an increase in the number of
S. Blockley isolates resistant to one or more
antibiotics, from 92.0% to  98.2% for imported
cases and from 57.4% to 88.7% for domestic cases
(3,14). In Thailand, isolates from human or other
sources also had high rates of resistance to
streptomycin, tetracycline, kanamycin, and
chloramphenicol and lower rates to ampicillin
and trimethoprim/sulfamethoxazole (15).
Nevertheless, few attempts at typing
S.  Blockley isolates with molecular methods
have been described, and these have been limited
to the characterization of plasmid content (2,16).
During the second and third quarters of 1998,
Enter-net reported higher numbers of S. Blockley
isolates than during the same period of the
previous year in several European countries (1).
The epidemiologic investigations conducted in
Germany, England and Wales, and Greece did
not confirm a source for this increase (17-19).
In this study, we characterized the Greek
outbreak isolates further, both with respect to
their antibiotic resistance phenotypes and DNA
fingerprints obtained by pulsed-field gel electro-
phoresis of genomic DNA.
The Study
The study sample consisted of 28 of 35
S.  Blockley strains isolated from May to
December 1998 (19), one strain from February
1999, and four epidemiologically unrelated
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During 1998, a marked increase (35 cases) in human gastroenteritis due to
Salmonella Blockley, a serotype rarely isolated from humans in the Western
Hemisphere, was noted in Greece. The two dominant multidrug-resistance phenotypes
(23 of the 29 isolates studied) were associated with two distinct DNA fingerprints,
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Table. Resistance phenotypes for isolates of Salmo-
nella Blockley in Greece
PFGEa Resistance
subtype phenotypeb Loca-
(n)        (n) Time span tionsc
A1 (1) AT (1) May 3, 1998 1
A2 (12) ATC (9), TCN (1), 1997; May 16- 6
  AN (1), AT (1)   Oct 13, 1998
A3 (3) ATC (1), ATN (1), Aug 24- 3
  TCN (1)   Oct 27, 1998
A4 (12) ATCN (8), ATN (2), Aug 17, 1998- 6
  ATC (1), TCN (1)   Feb 23, 1999
A5 (1) ATCN (1) Sep 29, 1998 1
A6 (1) AT (1) 1996 -
A7 (1) ATCN (1) 1997 -
A8 (2) ATC (1), AN (1) 1997;  Aug 10, 1
  1998
aPFGE, pulsed-field gel electrophoresis.
bA, kanamycin and streptomycin; T, tetracycline;
C, chloramphenicol; N, nalidixic acid.
cNumber of locations of isolation during the outbreak.
Figure 1. Sample pulsed-field gel electrophoresis
(PFGE) gel  of representative Salmonella Blockley
isolates, indicating common and unique DNA
fingerprints. Electrophoresis was through 1%
agarose/0.5 x TBE, in a CHEF DRIII apparatus
(BioRad Laboratories), at 14oC with a 120o switch
angle and a run time of 20 hours, with a linear ramp
of switching times from 5 to 32 seconds. Gels were
stained with 0.5 mg/L ethidium bromide and
documented under UV illumination by the EasyWin32
system (HeroLab, Germany). Images were assessed
visually, and different PFGE subtypes (A1, A2, ...)
were assigned to isolates with electrophoretic
patterns differing by one to three DNA fragments (23).
Gel images were also processed by the GelCompar
software (Applied Maths, Kortrijk, Belgium), and on the
basis of PFGE pattern similarities, a dendrogram was
constructed by using the Dice coefficient and
clustering by the unweighted pair group method,
which uses arithmetic averages (UPGMA) with a 2%
tolerance in band position difference.
Isol. no.: isolate number. PFGE: subtypes of PFGE type A. The
sizes, in kb, of lambda phage DNA  concatamers (New England
Biolabs) are shown to the left of the gel. All lanes are from the
same gel.
control strains: one from 1996 and three from
1997. All isolates were from human cases of
enteritis. Identification was performed by the
API 20E system (BioMerieux S.A., Marcy
l’Etoile, France) and serotyping with commer-
cially obtained antisera (BioMerieux) (20).
Susceptibility to kanamycin, streptomycin,
ampicillin, amoxicillin/clavulanic acid, cefepime,
tetracycline, chloramphenicol, trimethoprim/
sulfamethoxazole, gentamicin, nalidixic acid,
and ciprofloxacin was tested by a disk diffusion
assay according to National Committee for
Clinical Laboratory Standards guidelines (21).
Genomic DNA was prepared and digested with
XbaI (New England Biolabs) (22). Chi-square
tests or Fisher exact tests were used to calculate
two-tailed probabilities.
S. Blockley accounted for seven of the 13,199
salmonella isolates identified in Greece from
1976 to 1997. However, 35 gastroenteritis cases
due to this serotype were reported from May to
December 1998 (19). Twenty-nine S. Blockley
strains isolated from fecal specimens of patients
with gastroenteritis during May 1998 to February
1999, along with four epidemiologically unrelated
clinical isolates from 1996 and 1997, were
therefore studied for susceptibility to antibiotics.
The 1998 outbreak isolates were scattered
throughout Greece; S. Blockley was isolated later,
starting in August 1998, in northern Greece.
All isolates were susceptible to trimethoprim/
sulfamethoxazole, ampicillin, amoxicillin/
clavulanic acid, gentamicin, and ciprofloxacin
(Table). High resistance rates were observed to
tetracycline (100%), streptomycin and kanamy-
cin (90%), chloramphenicol (83%), and nalidixic
acid (52%). Six resistance phenotypes could be
distinguished (Table) with the two major
phenotypes of outbreak isolates being resistant
to kanamycin, streptomycin, tetracycline, and
chloramphenicol (ATC) or kanamycin, strepto-
mycin, tetracycline, chloramphenicol, and nalid-
ixic acid (ATCN). Most (76%) strains isolated
after August 24, 1998, were nalidixic acid-
resistant (resistance phenotypes ATCN, TCN,
ATN), unlike strains isolated up to August 17,
1998 (17%) (1.29 <RR = 3.03 <7.11, p = 0.005).
When pulsed-field gel electrophoresis was
used to obtain DNA fingerprints for these
isolates (Figure 1), all belonged to the same
type, A, although eight subtypes, A1-A8, could
be distinguished on the basis of one to three DNA62 62 62 62 62 Emerging Infectious Diseases Vol. 6, No. 1, January–February 2000
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Figure 2. Dendrogram of similarity among the
observed pulsed-field gel electrophoresis patterns. A
percentage scale of similarity is indicated at the top.
Numbers in parentheses refer to the number of
isolates with the indicated pulsed-field gel electro-
phoresis pattern.
fragment differences (Figures 1, 2). Two of the
four isolates from previous years belonged to
unique subtypes A6 and A7; the other two
belonged to subtypes A2 and A8, shared by
outbreak isolates (Table). In contrast, 93% of the
1998 outbreak strains yielded PFGE patterns
common to two or more isolates. Indeed, most
outbreak isolates were grouped in subtypes A2
and A4, consisting of 11 and 12 isolates,
respectively (Table).
Pulsed-field gel electrophoresis subtypes
were associated with resistance phenotypes.
Most resistance phenotype ATC isolates be-
longed to subtype A2 (3.03. <RR = 11.86 <46.5,
p = 0.0000098), while most resistance phenotype
ATCN isolates belonged to A4 (2.76 <RR = 7.11
<18.30, p = 0.0000416). In addition, most isolates
in the two major subtypes appearing before
August 17, 1998, belonged to the A2 group, while
most isolates appearing after August 24, 1998,
belonged to the A4 group (1.47 <RR = 9.82
<65.45, p = 0.0006). Finally, unlike A4, the
earlier A2 subtype was not isolated in northern
Greece.
Conclusions
Our results indicate that PFGE is useful in
distinguishing epidemiologically related
S.  Blockley isolates since two of the four
nonoutbreak isolates displayed unique PFGE
patterns, A7 and A8, while PFGE patterns A2
and A4 grouped most of the 29 outbreak isolates
(11 and 12, respectively).
These two chromosomal fingerprints, differ-
ing by two DNA fragments, were associated with
two distinct resistance phenotypes. The resis-
tance phenotype of A4 isolates, ATCN, was
identical to the earlier resistance phenotype of
A2 isolates, ATC, except for the resistance to
nalidixic acid. Nevertheless, these two PFGE/
antibiotic resistance types, A2/ATC and A4/
ATCN, displayed a clear distribution both in time
and space.
The data may, therefore, indicate two main
sources for the outbreak. Alternatively, and
perhaps more likely, these two closely related
types may together constitute the outbreak
clone, evolved with time to acquire resistance to
nalidixic acid. Resistance may well have
originated in the food source, since several
antibiotic classes are used as feed supplements in
animal rearing and aquaculture in Greece:
sulfonamides (trimethoprim/sulfathiazine), tet-
racyclines (oxytetracycline), and quinolones
(oxolinic acid). However, as in other European
countries (17,18), the epidemiologic investiga-
tion did not locate a common source to account
for the wide geographic spread of cases (19).
Although travel was not mentioned in the Greek
patients’ questionnaire responses, the possibility
that the source was an imported food cannot be
ruled out. The association with smoked eel of
Italian origin in the German outbreak has not
been microbiologically confirmed (17). The only
other previous European report of a human
outbreak attributed to S. Blockley, probably
from vegetables contaminated by this organism,
which was prevalent in irrigation water in the
Spanish region of Granada, is anecdotal (13). A
documented S. Blockley enteritis epidemic in a
U.S. hospital in 1966 was attributed to
contaminated ice cream; however, this was also
not microbiologically confirmed (7).
While this serotype may remain important in
Europe, its high rates of resistance to
kanamycin, streptomycin, tetracycline, and
chloramphenicol, which were in agreement with
studies from the Far East (3) and Spain (12), are
cause for concern. Unlike the Far Eastern
strains, no resistance to ß-lactam antibiotics or
cotrimoxazole was observed in our study. The63 63 63 63 63 Vol. 6, No. 1, January–February 2000 Emerging Infectious Diseases
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two dominant resistant phenotypes of S. Blockley
from natural polluted waters in Spain were
sulfonamides, streptomycin, and tetracycline;
and neomycin, streptomycin, kanamycin, tetra-
cycline, and chloramphenicol (12), as in the
Greek strains, except for the absence of
resistance to nalidixic acid.
In agreement with differences in animal
reservoirs and transmission routes and therefore
the mechanism of resistance acquisition among
different  Salmonella serotypes, the main
patterns of resistance observed in S. Blockley
were distinct from those predominating in the
two major serotypes from isolates of both human
and animal food origin in Greece. In S. Enteritidis,
the most frequent resistance phenotype was
resistance to ampicillin (24), while in
S.  Typhimurium, the most frequent resistant
phenotype was resistance to sulfonamides and
streptomycin (A. Markogiannakis, P.T. Tassios,
N.J. Legakis, unpub. obs.). Furthermore, the
considerably high rate of resistance to nalidixic
acid is equally unprecedented in both the Far
Eastern and Spanish S. Blockley isolates and in
other salmonella serotypes from Greece. Since
resistance to nalidixic acid can be a precursor of
resistance to fluoroquinolones, one of the two
drug classes of choice for invasive salmonella
disease, this feature of these S. Blockley strains
is particularly disturbing. S. Blockley, previ-
ously a prevalent serotype in the Far East but
rare elsewhere, nevertheless posed a public
health problem in several European countries.
The source of the European outbreaks, however,
remains unclear. Given the increased interna-
tional commerce in food, a collaborative study
would be useful in identifying potential
similarities between the recent European strains
and established strains from the Far East.
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